Trends in abnormal cancer screening results in the United States of America

Journal of Medical Screening

Volumn 14, Issue 2, 2007, Pages 67-72

  Yabroff, K Robin ^a   Freedman, Andrew ^a   Brown, Martin L ^a   Ballard Barbash, Rachel ^a   McNeel, Timothy ^b   Taplin, Stephen ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER SCREENING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PAPANICOLAOU TEST; PREVALENCE; STATISTICAL SIGNIFICANCE; UNITED STATES; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; FEMALE; HEALTH CARE SURVEYS; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PREVALENCE; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 34447502396     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/096914107781261909     Document Type: Article

References (45)

1. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of evidence for the US. Preventive Services Task Force. Ann Intern Med 2002;137:347-60
2. Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003;53:141-69
3. US Preventive Services Task Force. Guide to Clinical Preventive Services: Report of the US Preventive Services Task Force. 2nd edn, Baltimore, MD: Williams & Wilkins, 1996
4. US Preventive Services Task Force. Screening for cervical cancer: recommendations and rationale. Am J Nurs 2003;103:101-9
5. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-62
6. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 national health interview surveys. J Natl Cancer Inst 2001;93:1704-13
7. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003;97:1528-40
8. Papanicolaou GN, Traut HF. The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Obstet Gynecol 1941;42:193-205
9. Helms LJ, Melnikow J. Determining costs of health care services for cost-effectiveness analyses: the case of cervical cancer prevention and treatment. Med Care 1999;37:652-61
10. Lafata JE, Simpkins J, Lamerato L, Poisson L, Divine G, Johnson CC. The economic impact of false-positive cancer screens. Cancer Epidemiol Biomarkers Prev 2004;13:2126-32
11. Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 1991;114:657-61
12. Lowe JB, Balanda KP, Del Mar C, Hawes E. Psychologic distress in women with abnormal findings in mass mammography screening. Cancer 1999;85:1114-18
13. Lipkus IM, Halabi S, Strigo TS, Rimer BK. The impact of abnormal mammograms on psychosocial outcomes and subsequent screening. Psycho-Oncology 2000;9:402-10
14. Aro AR, Absetz SP, van Elderen TM, van der Ploeg E, van der Kamp LJ. False-positive findings in mammography screening induces short-term distress-breast cancer-specific concern prevails longer. Eur J Cancer 2000;36:1089-97
15. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;137:132-41
16. American College of Physicians. Clinical Guideline: Part 1: Suggested technique for fecal occult blood testing and interpretation in colorectal cancer screening. Ann Internal Med 1997;126:808-10
17. Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines on screening and surveillance for the early detection of adenomatous polyps and colorectal cancer: update 2001. CA Cancer J Clin 2001;51:44-54
18. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected US population. Healthy People 2010: Statisitcal Notes 2001;20:1-2
19. Research Triangle Institute. SUDAAN User's Manual, Release 8.0. Research Triangle Park, NC: Research Triangle Institute, 2001
20. Ransohoff DF, Lang CA, Kuo HS. Colonoscopic surveillance after polypectomy: considerations of cost effectiveness. Ann Intern Med 1991;114:177-82
21. Rakowski W, Breen N, Meissner H, et al. Prevalence and correlates of repeat mammography among women aged 55-79 in the year 2000 National Health Interview Survey. Prev Med 2004;39:1-10
22. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003;138:168-75
23. Stenkvist B, Bergstrom R, Eklund G, Fox CH. Papanicolaou smear screening and cervical cancer. What can you expect? JAMA 1984;252:1423-6
24. . The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. JAMA 1989;262:931-4
25. Davey DD, Woodhouse S, Styer P, Stastny J, Mody D. Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 2000;124:203-11
26. Davey DD, Nielson ML, Naryshkin S, Robb JA, Cohen T, Kline TS. Atypical squamous cells of undetermined significance: current laboratory practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 1996;120:440-4
27. Centers for Disease Control and Prevention. Regulatory closure of cervical cytology laboratories: recommendations for a public health response. MMWR 1997;46(No. RR-17):1-20
28. Ries LAG, Kosary CL, Hankey BF, Edwards BK. SEER Cancer Statistic Review, 1973-1996. Bethesda, Maryland: National Cancer Institute, 1999. Ref Type: Report
29. Hendrick RE. Quality assurance in mammography. Accreditation, legislation, and compliance with quality assurance standards. Radiol Clin North Am 1992;30:243-55
30. Conway BJ, Suleiman OH, Rueter FG, Antonsen RG, Slayton RJ. National survey of mammography facilities in 1985, 1988, and 1992. Radiology 1994;191:323-30
31. Hendrick RE, Chrvala C, Plott CM, Cutter GR, Jessop NW, Wilcox-Buchalla P. Improvement in mammography quality control: 1987-1995. Radiology 1998;207:663-8
32. Fintor L, Brown M, Fischer R, et al. The impact of mammography quality improvement legislation in Michigan: implications for the national Mammography Quality Standards Act. Am J Public Health 1998;88:667-71
33. Bassett LW, Hendrick RE, Bassford TL, et al. Quality Determinants of Mammography. Clinical Practice Guideline No. 13. AHCPR Publication No. 95-0632. Rockville, MD: Agency for Healthcare Policy and Research, Public Health Service, US Department of Health and Human Services, 1994. Ref Type: Report
34. Cancer Intervention and Surveillance Modelling Network. http://cisnet. cancer.gov/about/ (Accessed 22 May 2007)
35. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast exams. N Engl J Med 1998;338:1089-96
36. Christiansen CL, Wang F, Barton MB, et al. Predicting the cumulative risk of false-positive mammograms. J Natl Cancer Inst 2000;92:1657-66
37. Hofvind S, Thoresen S, Tretli S. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program. Cancer 2004;101:1501-7
38. Brown ML, Houn F, Sickles EA, Kessler LG. Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures. Am J Roentgenol 1995;165:1373-7
39. Raffle AE, Alden B, Quinn M, Babb PJ, Brett MT. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ 2003;326:901-5
40. Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst 1993;85:566-70
41. Hiatt RA, Perez-Stable EJ, Quesenberry Jr CP, Sabogal F, Otero-Sabogal R, McPhee SJ. Agreement between self-reported early cancer detection practices and medical audits among Hispanic and non Hispanic white health plan members in northern California. Prev Med 1995;24:278-85
42. Newell SA, Girgis A, Sanson-Fisher RW, Savolainen NJ, Hons BA. The accuracy of self-reported health behaviors and risk factors relating to cancer and cardiovascular disease in the general population: a critical review. Am J Prev Med 1999;17:211-29
43. Paskett ED, Tatum CM, Mack DW, Hoen H, Case LD, Velez R. Validation of self-reported breast and cervical cancer screening tests among low-income minority women. Cancer Epidemiol Biomarkers Prev (US) 1996;5:721-6
44. Perez-Stable EJ, Otero-Sabogal R, Sabogal F, McPhee SJ, Hiatt RA. Selfreported use of cancer screening tests among Latinos and Anglos in a prepaid health plan. Arch Intern Med (US) 1994;154:1073-81
45. Desai MM, Bruce ML, Desai RA, Druss BG. Validity of self-reported cancer history: a comparison of health interview data and cancer registry records. Am J Epidemiol 2001;153:299-306